Riskpilot← Back to searchSign inGet full accesseWell AB
ABActiveOrg 5567036271Skogsstjärnevägen 59General medical practice activities · NACE 8621Est. 20061-4 employees
Revenue 2024
SEK 142K
-96% vs 2023
EBITDA margin
-18.2%
-103% vs 2023
Equity ratio
81.7%
Financial strength
Net profit 2024
SEK 673K
0% vs 2023
| Revenue | SEK 142K | -96% |
| EBITDA | SEK -26K | -103% |
| Net profit | SEK 673K | +0% |
| Total assets | SEK 1,2M | -13% |
| Equity | SEK 965K | +21% |
| Employees | — | — |
Legal name
eWell AB
Org number
5567036271
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 maj 2006
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget ska bedriva utveckling, drift, utbildning, redovisning och andra liknande tjänster inom hälsa, friskvård och sjukvård. Verksamheten bedrivs på internet samt i fysiska mottagningar. Även handel med produkter och digitala system inom området hälsa, friskvård och sjukvård.
Address
Skogsstjärnevägen 59
Email
johanemius@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 123 | 12 | 0 | 41 | 1 717 | 3 252 | 142 |
| Staff expenses | — | — | — | — | — | — | — | −915 | −1 317 | −25 |
| EBITDA | 112 | −28 | 133 | 101 | −1 | −4 | −1 | 724 | 847 | −26 |
| Depreciation & amort. | −33 | −32 | −24 | −21 | −0 | −0 | −0 | — | — | — |
| EBIT | 79 | −60 | 109 | 80 | −1 | −4 | −1 | 724 | 847 | −26 |
| Net financials | −6 | −5 | −4 | — | — | — | −1 | −1 | 2 | 699 |
| Profit before tax | 73 | −65 | 106 | 80 | −1 | −4 | −2 | 723 | 848 | 673 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −135 | −176 | — |
| Net profit | 73 | −65 | 106 | 80 | −1 | −4 | −2 | 588 | 672 | 673 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 104 | 46 | 29 | 0 | 0 | 0 | 9 | 864 | 1 352 | 1 181 |
| Equity | −127 | −192 | −87 | −7 | −7 | −12 | −13 | 575 | 797 | 965 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 231 | 238 | 116 | 7 | 7 | 12 | 22 | 289 | 556 | 217 |
| Total debt | 231 | 238 | 116 | 7 | 7 | 12 | 22 | 289 | 556 | 217 |
EBITDA margin
-18.2%
This company
15.8%
Market median
-215% vs market
20152024
Equity ratio
81.7%
This company
38.2%
Market median
+114% vs market
20152024
Return on equity
69.8%
This company
18.4%
Market median
+279% vs market
20152024
Net profit margin
475.7%
This company
8.1%
Market median
+5773% vs market
20152024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20152024
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-09-01 – 2015-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PI Audit | Audit | 2021 | — | — |
CJ Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
eWell AB 
Wellgo Health ABBoard members of eWell AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Inge Nivard | Audit | 0 companies |
| Carl Johan Ronald Emius | Chief Executive Officer | 0 companies |
| Margita Cecilia Emius | Deputy Board Member | 0 companies |
| Anders Simon Isaksson Aurelius | Deputy Board Member | 0 companies |